≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Open bite that required surgery (Lefort1 or BSSRO)

Endpoint Browser PheWeb

K11_OPEN_BITE_SURGERY

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • OPER_LEFORT1_BSSRO
1648

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K07.24
  • Cause of death: ICD-10 — K07.24

2 out of 7 registries used, show all original rules.

361

4. Check minimum number of events

None

361

5. Include endpoints

None

361

6. Filter based on genotype QC (FinnGen only)

361

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2132 1470 646
Only index persons 2100 1460 640
Unadjusted period prevalence (%)
Whole population 0.03 0.04 0.02
Only index persons 0.04 0.05 0.02
Median age at first event (years)
Whole population 27.35 27.64 26.66
Only index persons 27.38 27.65 26.75

-FinnGen-

Key figures

All Female Male
Number of individuals 361 282 79
Unadjusted period prevalence (%) 0.08 0.10 0.03
Median age at first event (years) 29.96 29.30 32.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
312
Matched controls
3119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.24
ICD-10 Finland
Open bite
+∞
323.0
312
21
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
427.2
281.2
249
28
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
1001.6
269.1
227
8
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
321.1
252.0
230
27
SBB10
NOMESCO Finland
Teeth copy
143.5
247.5
266
120
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
190.8
232.9
226
42
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
363.8
224.7
204
16
EEC05
NOMESCO Finland
Le Fort I osteotomy
4609.6
221.6
187
*
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
291.0
220.4
204
20
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
277.1
219.4
204
21
K07.13
ICD-10 Finland
Retrognaty, mandibular
244.6
206.7
195
21
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
212.5
196.1
188
22
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
274.5
170.4
161
12
EB1MA
NOMESCO Finland
Cephalometry with X-ray
132.7
168.2
171
28
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
68.3
160.5
184
64
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
175.9
160.3
158
18
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
167.7
140.6
140
15
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
45.1
122.5
153
65
SAA04
NOMESCO Finland
Special inverstigation of mouth
36.9
115.9
153
79
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
77.1
111.1
123
26
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
119.9
94.8
99
12
SJC00
NOMESCO Finland
Bracket with fixed attachment
996.2
81.3
76
*
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
71.5
78.3
88
17
SXC05
NOMESCO Finland
Other oral or dental procedure
19.9
77.5
124
100
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
39.0
74.0
94
34
SJB60
NOMESCO Finland
External device grinding and adaptation
56.0
70.8
83
20
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
55.1
69.7
82
20
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
83.1
69.2
76
12
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
21.1
67.6
104
72
K07.14
ICD-10 Finland
Retrognaty, maxillary
412.0
67.3
65
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
10.2
66.3
157
281
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
74.7
62.7
70
12
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
236.3
58.2
58
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
30.0
56.2
76
33
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
173.5
55.9
57
*
K07.60
ICD-10 Finland
Snapping jaw
12.5
55.3
108
127
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
18.4
54.9
88
65
K07.10
ICD-10 Finland
Asymmetry of jaw
169.8
54.8
56
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
10.2
52.1
115
169
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
207.0
51.6
52
*
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
282.4
48.5
48
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.0
47.4
198
702
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
+∞
47.1
44
*
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
115.8
46.3
49
5
SAA03
NOMESCO Finland
Extended examination of mouth
6.0
45.7
234
1035
K07.23
ICD-10 Finland
Deep bite
30.0
43.9
59
24
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
99.4
39.9
43
5
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
10.0
38.4
82
107
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
52.2
34.7
41
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.5
34.2
208
961
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
71.7
33.9
38
6
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
122.5
31.3
33
*
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
35.0
31.2
40
13
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
332.9
30.4
30
*
SXC03
NOMESCO Finland
Other oral or dental procedure
35.8
29.8
38
12
EBB10
NOMESCO Finland
Insertion of dental implant
49.0
29.4
35
8
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
165.3
29.2
30
*
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
21.0
26.4
39
21
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
102.2
26.1
28
*
SJA02
NOMESCO Finland
Plan for orthodontic care
282.7
26.1
26
*
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
34.2
24.2
31
10
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
36.7
23.8
30
9
EDC30
NOMESCO Finland
Genioplasty
+∞
23.2
22
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
38.2
22.5
28
8
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
28.9
21.8
29
11
EBA10
NOMESCO Finland
Surgical removal of tooth
3.8
21.5
112
402
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
7.0
20.7
53
88
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
112.2
19.8
21
*
EEC02
NOMESCO Finland
Rapid expansion of maxilla
112.2
19.8
21
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
17.3
19.2
30
19
Z3229
NOMESCO Finland
Other healthcare associate professional
6.2
18.8
53
100
EBB15
NOMESCO Finland
Insertion of dental implant abutment
106.5
18.8
20
*
EB1WA
NOMESCO Finland
NA
27.0
18.5
25
10
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
21.7
18.1
26
13
ZXA10
NOMESCO Finland
Bilateral
4.0
17.6
80
250
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.8
17.1
40
58
K01.0
ICD-10 Finland
Embedded teeth
11.0
16.9
32
32
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
+∞
16.8
16
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
16.5
64
172
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
35.4
15.9
20
6
K00.00
ICD-10 Finland
Hypodontia
20.6
15.8
23
12
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.9
15.7
45
86
SAA02
NOMESCO Finland
Basic examination of mouth
3.2
15.3
259
1896
SDA02
NOMESCO Finland
Parodonthologic therapy
2.7
15.3
145
754
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
14.2
15.0
25
19
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
59.7
14.9
17
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.1
14.6
33
45
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
10.1
13.8
27
29
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.7
13.4
114
545
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
29.8
13.1
17
6
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
20.1
13.1
19
10
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
11.2
13.0
24
23
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.4
12.4
64
218
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
12.3
100
460
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
22.4
12.1
17
8
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
67.5
11.7
13
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
6.5
11.7
30
50
EB1TW
NOMESCO Finland
3D modelling of dentition
+∞
11.5
11
*
ZXX07
NOMESCO Finland
Extent of procedure, 7 units
+∞
11.5
11
*
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
15.8
11.4
18
12
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
29.2
10.8
14
5
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
113.6
10.5
11
*
EEC00
NOMESCO Finland
Segmental osteotomy of maxilla
+∞
10.5
10
*
EFB50
NOMESCO Finland
Orthodontic procedure connected with ortognathic surgery
+∞
10.5
10
*
J01CE02
ATC
phenoxymethylpenicillin; oral
2.5
10.1
256
2012
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
27.0
9.9
13
5
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
56.8
9.7
11
*
SAA01
NOMESCO Finland
Simple examination of mouth
2.4
9.6
255
2016
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.7
9.5
32
74
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
+∞
9.4
9
*
TEG00
NOMESCO Finland
Punction of mandibular joint
+∞
9.4
9
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.1
9.3
144
890
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
9.2
35
92
K07.61
ICD-10 Finland
Cracking jaw joint
6.3
8.6
22
37
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.1
8.6
124
739
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
92.4
8.5
9
*
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
92.4
8.5
9
*
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
9.8
8.4
16
17
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
+∞
8.4
8
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.9
8.2
52
203
M79.1
ICD-10 Finland
Myalgia
2.6
7.7
58
251
K07.4
ICD-10 Finland
Malocclusion, unspecified
8.4
7.7
16
20
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
25.7
7.6
10
*
SPB10
NOMESCO Finland
Production of temporary crone to tooth
25.7
7.6
10
*
K06.00
ICD-10 Finland
Local gingivore traction
8.0
7.5
16
21
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
81.9
7.4
8
*
K07.68
ICD-10 Finland
Other disorders of the jaw joint
13.8
7.4
12
9
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.5
7.4
25
59
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
+∞
7.3
7
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
16.2
7.3
11
7
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
20.6
7.2
10
5
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
7.0
106
630
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.9
6.9
21
45
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
41.0
6.8
8
*
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
4.1
6.8
25
65
OIKK
NOMESCO Finland
NA
5.4
6.7
19
37
M01AE01
ATC
ibuprofen; systemic, rectal
3.3
6.7
297
2669
R4110
NOMESCO Finland
Physiotherapy
2.1
6.5
78
421
WX402
NOMESCO Finland
General anaesthesia
2.3
6.4
60
290
SDA01
NOMESCO Finland
Simple parodonthologic therapy
2.0
6.4
103
625
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
+∞
6.3
6
*
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
+∞
6.3
6
*
EEC99
NOMESCO Finland
Other reconstructive operations on maxilla
+∞
6.3
6
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
27.3
6.3
8
*
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
3.9
6.0
23
62

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
157
1161
1.62
4.77
3.0
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
186
1435
1.61
4.73
3.6
4.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
58
3.21
4.70
3.3
12.4
%
1.3
1.5
0.61
18
51
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
56
3.14
4.30
3.4
12.8
%
0.9
0.9
0.03
17
51
(3035350) Ketones [Presence] in Urine by Test strip
189
1487
1.57
4.27
2.9
3.0
estimate
0.0
0.0
0.00
45
312
(3009261) Glucose [Presence] in Urine by Test strip
190
1499
1.56
4.22
3.0
3.0
estimate
0.0
0.0
0.50
44
308
(3021601) Nitrite [Presence] in Urine by Test strip
187
1480
1.55
4.03
4.1
4.2
estimate
0.0
0.0
0.40
46
319
(3041096) Erythrocytes [Presence] in Urine by Automated
123
907
1.54
3.56
2.5
2.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
301
2728
1.62
2.96
10.4
11.9
%
13.3
13.4
0.42
296
2683
(40761511) CBC panel - Blood by Automated count
345
3260
2.31
2.86
9.9
9.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
6
8.43
2.75
3.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
40
2.81
2.39
1.5
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
8
6.32
2.38
3.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
240
1.70
2.34
4.4
4.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
235
2066
1.39
2.33
4.0
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
422
1.54
2.29
1.5
1.5
pmol/l
84615835.8
39788229.6
0.21
52
377
(3029937) Albumin [Presence] in Urine by Test strip
104
803
1.41
2.25
3.2
3.2
estimate
0.0
0.0
1.08
46
319
(3019309) Folate [Moles/volume] in Red Blood Cells
47
308
1.60
2.23
1.4
1.6
nmol/l
1175.4
1157.1
0.06
39
241
(3013707) Erythrocyte sedimentation rate by Westergren method
239
2118
1.38
2.19
4.0
3.5
mm/h
8.1
8.4
0.19
233
1985
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
267
2411
1.41
2.18
4.4
4.2
pmol/l
14.4
14.3
0.13
248
2261
(3008152) Bicarbonate [Moles/volume] in Arterial blood
18
88
2.10
2.15
3.0
12.8
mmol/l
24.4
24.8
0.10
18
79
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
10
5.05
2.07
1.0
2.3
ug/l
0.9
1.7
—
5
10
(3015736) pH of Urine
143
1181
1.35
2.02
2.7
2.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
13
57
2.33
2.00
2.8
13.6
mmol/l
1.5
1.1
0.63
13
46
(3026389) Candida sp identified in Specimen by Organism specific culture
9
34
2.69
1.87
1.2
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
8
28
2.90
1.87
2.4
2.3
mmol/l
8.3
7.0
—
8
28
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
80
611
1.40
1.82
1.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
558
1.41
1.81
1.4
1.3
iu/ml
27.3
25.5
0.04
24
173
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
18
3.37
1.75
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
322
3050
1.52
1.68
9.0
10.0
mg/l
18.2
18.7
0.12
254
2296
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
166
1.68
1.67
1.4
1.4
u/l
9.7
9.8
0.01
22
138
(1761482) Bacteria [#/volume] in Urine by Culture
10
43
2.36
1.61
3.0
2.7
—
—
—
0
0
(3039000) Anion gap in Blood
8
32
2.53
1.60
3.6
21.4
mmol/l
12.4
10.7
—
8
27
(4034850)
16
85
1.92
1.57
8.3
8.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
85
1.92
1.57
2.4
10.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
8
33
2.46
1.54
3.6
20.8
mmol/l
106.1
105.1
—
8
28
(3044941) Cell count panel - Synovial fluid
7
27
2.62
1.52
1.7
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
45
0.00
1.51
0.0
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
558
1.36
1.50
1.3
1.3
u/ml
2.3
8.6
2.38
27
240
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
271
1.49
1.47
1.1
1.3
iu/l
23.6
21.9
0.11
33
232
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
239
1.51
1.44
1.8
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
198
1.56
1.43
1.2
1.2
—
—
—
0
0
(44813793)
7
29
2.44
1.40
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
133
1135
1.27
1.38
2.1
2.2
nmol/l
76.9
72.5
1.03
127
1058
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
233
1.51
1.38
1.2
1.3
miu/ml
285.3
263.4
0.11
17
124
(3026782) Osmolality of Urine
62
476
1.37
1.37
2.2
2.2
mosm/kgh2o
506.5
566.8
1.19
53
405
(3021387) Prolactin [Units/volume] in Serum or Plasma
37
259
1.48
1.36
1.4
1.5
mu/l
317.5
281.5
0.29
32
229
(3004616) Nuclear Ab [Presence] in Serum
0
38
0.00
1.35
0.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
135
1158
1.26
1.34
1.7
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
47
346
1.41
1.33
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
9
174
0.50
1.33
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
150
1304
1.26
1.33
6.9
7.6
e9/l
0.0
0.0
0.71
132
1074
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
120
1017
1.27
1.31
1.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
204
1.51
1.27
1.4
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
296
2795
1.33
1.27
5.0
4.7
mu/l
1.8
2.1
0.44
280
2658
(3003327) Ova and parasites identified in Stool by Light microscopy
22
139
1.62
1.26
1.3
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
300
2846
1.32
1.18
3.4
3.5
mmol/l
2.8
2.9
0.24
291
2700
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
208
1.48
1.17
1.4
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
72
1.84
1.16
1.5
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
72
1.84
1.16
2.9
2.8
%
33.2
51.4
1.63
13
72
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
35
0.00
1.15
0.0
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
111
0.44
1.15
1.2
2.9
kpa
5.3
5.1
—
5
100
(3009343) pH of Capillary blood
5
111
0.44
1.15
1.2
2.9
—
7.4
—
0
10
(4035726)
9
163
0.54
1.11
1.0
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
97
1.68
1.08
1.1
1.1
u/ml
0.3
1.3
—
5
35
(40761535) Cells panel - Urine sediment
26
179
1.49
1.06
3.9
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
643
1.27
1.06
1.6
1.9
mg/l
2.5
2.7
0.63
69
553
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
286
2710
1.27
1.04
3.0
3.0
mmol/l
1.2
1.2
0.71
278
2572
(3019150) Specific gravity of Urine by Refractometry
78
645
1.27
1.04
3.3
3.1
kg/l
1.0
1.0
—
7
83
(3027801) Oxygen [Partial pressure] in Arterial blood
24
164
1.50
1.02
2.6
10.5
kpa
14.2
13.8
0.12
24
155
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
24
164
1.50
1.02
2.6
10.5
kpa
4.9
5.2
0.82
24
154
(40760892) CBC W Ordered Manual Differential panel - Blood
93
787
1.24
1.01
3.3
4.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
48
1.90
1.01
1.3
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
29
207
1.44
1.00
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
107
922
1.23
0.99
2.1
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
299
2854
1.28
0.98
7.7
9.4
mmol/l
3.9
3.9
0.22
293
2757
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
30
0.00
0.97
0.0
5.1
—
41.0
—
0
30
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
36
1.96
0.97
1.0
1.1
mg/l
206.4
218.8
—
7
31
(3021447) Carbon dioxide [Partial pressure] in Venous blood
22
150
1.50
0.95
2.0
3.0
kpa
5.9
5.8
0.06
22
144
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
296
2825
1.27
0.95
3.4
3.3
mmol/l
4.8
4.8
0.12
286
2693
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
295
2816
1.26
0.93
3.3
3.3
mmol/l
1.5
1.5
1.76
288
2680
(3024928) Oxygen saturation in Venous blood
6
28
2.16
0.92
1.2
2.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
23
160
1.47
0.91
2.5
10.8
mmol/l
2.6
1.1
0.69
16
123
(3044640) Blood type and Crossmatch panel - Blood
102
882
1.22
0.91
1.6
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
11
63
1.77
0.91
1.9
1.8
%
13.1
13.0
0.23
11
63
(3021788) Differential panel - Synovial fluid
6
29
2.09
0.89
1.5
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
43
1.88
0.88
1.4
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
17
112
1.54
0.86
1.6
2.4
e9/l
72.7
78.8
—
10
82
(3026008) Bacteria identified in Urine by Culture
86
735
1.22
0.86
2.8
2.2
—
—
—
0
0
(3012544) pH of Venous blood
22
155
1.45
0.83
2.0
3.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
65
1.71
0.83
1.0
1.3
ug/g
361.9
357.7
—
5
39
(4027681)
6
32
1.89
0.82
1.0
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.3
—
34.4
—
0
5
(3019198) Lymphocytes [#/volume] in Blood
166
1520
1.17
0.76
5.5
5.5
e9/l
1.9
2.1
1.04
153
1390
(3002173) Hemoglobin [Mass/volume] in Arterial blood
19
133
1.45
0.75
2.8
12.0
g/l
124.5
122.4
0.18
19
127
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
78
671
1.21
0.73
1.7
1.6
mg/l
0.7
0.7
0.01
59
482
(3007164) IgA [Mass/volume] in Serum or Plasma
66
773
0.82
0.73
1.3
1.4
g/l
2.0
2.1
0.61
45
500
(36660697) Celiac disease serology panel - Serum
39
310
1.29
0.73
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
274
0.71
0.72
1.7
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
252
2392
1.18
0.72
3.9
4.0
mmol/mol
37.1
37.4
0.21
240
2276
(3007853) Bacteria identified in Skin by Aerobe culture
40
320
1.28
0.71
1.7
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
34
267
1.30
0.70
1.5
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
313
1.28
0.68
1.6
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
527
1.21
0.66
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
59
499
1.22
0.66
1.5
2.3
e6/l
5.3
8.8
0.73
52
435
(3044889) 12 lead EKG panel
182
1692
1.15
0.66
2.4
2.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
324
3154
1.27
0.66
8.4
7.9
u/l
25.1
25.7
0.20
315
3076
(3019550) Sodium [Moles/volume] in Serum or Plasma
295
2847
1.20
0.64
7.7
9.4
mmol/l
139.6
139.5
0.05
290
2766
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
2.0
1.1
pmol/l
235.2
459.3
—
5
23
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
27
345
0.77
0.64
2.1
2.3
e6/l
2.2
4.4
1.05
15
169
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
63
1.60
0.62
1.0
1.1
u/ml
1.2
9.3
—
5
22
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
234
2223
1.15
0.60
2.7
2.8
u/l
28.1
34.4
1.65
223
2143
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
20
0.00
0.60
0.0
2.1
—
59.6
—
0
14
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
21
0.00
0.60
0.0
21.1
—
6.9
—
0
15
(3015183) Erythrocyte sedimentation rate
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
10
150
0.66
0.59
1.8
6.4
mmol/l
5.6
6.9
—
10
145
(3001122) Ferritin [Mass/volume] in Serum or Plasma
174
1622
1.14
0.59
3.0
2.9
ug/l
58.6
72.5
1.35
168
1538
(40768804) Tissue Pathology biopsy report
106
1171
0.87
0.59
1.4
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
112
1013
1.15
0.59
2.2
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
53
1.52
0.59
1.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
307
0.77
0.58
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
307
0.77
0.58
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
81
1.50
0.57
1.0
1.1
u/ml
0.9
7.5
—
6
42
(3009542) Hematocrit [Volume Fraction] of Blood
312
3034
1.21
0.57
9.7
10.3
%
40.2
40.5
0.34
255
2575
(3034770) Mitochondria Ab [Titer] in Serum
5
86
0.58
0.57
1.4
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
306
0.77
0.57
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
306
0.77
0.57
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
90
0.55
0.56
1.6
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
90
0.55
0.56
1.4
1.2
—
66.3
—
0
8
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
872
1.15
0.55
1.3
1.3
u/ml
2.3
1.6
0.16
29
242
(3013650) Neutrophils [#/volume] in Blood by Automated count
179
1680
1.13
0.53
6.6
8.2
e9/l
3.6
4.0
2.49
163
1479
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
64
1.42
0.52
1.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
19
144
1.34
0.51
2.8
11.4
%
95.3
96.3
0.17
19
136
(40761536) Microorganisms panel - Urine sediment
35
289
1.23
0.51
2.3
3.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
75
1.48
0.51
1.0
1.1
u/ml
4.4
9.3
—
6
23
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
355
0.80
0.51
1.9
2.2
e6/l
0.6
0.8
0.50
17
179
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
256
0.77
0.50
1.5
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
156
1457
1.12
0.50
5.7
5.6
e9/l
0.0
0.0
0.22
142
1310
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
365
1.20
0.49
1.8
2.7
ng/l
6.8
462.7
1.15
17
185
(3013115) Eosinophils [#/volume] in Blood
162
1519
1.12
0.48
5.6
6.0
e9/l
0.2
0.2
0.04
149
1381
(3000330) Specific gravity of Urine by Test strip
14
102
1.39
0.48
3.9
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
219
1.25
0.46
2.0
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
81
0.61
0.46
1.2
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
81
0.61
0.46
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
247
1.23
0.46
1.3
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
73
653
1.15
0.45
2.2
2.0
u/l
112.4
264.3
0.88
67
623
(3004588) Protein electrophoresis panel - Serum or Plasma
13
95
1.38
0.44
1.1
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
51
1.38
0.44
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
251
0.78
0.44
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
27
326
0.81
0.43
1.1
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
14
184
0.75
0.43
1.6
2.0
u/ml
22.0
37.7
0.62
14
175
(3005033) Fetal Nuchal fold Thickness US
20
250
0.79
0.43
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
91
831
1.13
0.42
2.6
2.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
154
1450
1.11
0.41
5.5
5.5
e9/l
0.5
0.5
1.67
142
1303
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
84
764
1.13
0.41
1.9
2.7
ng/l
16.2
24.2
0.43
34
314
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
1.0
—
0
5
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(4024509)
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
487
1.15
0.40
2.3
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
105
0.66
0.40
1.4
4.7
mmol/l
26.0
24.7
—
7
105
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
333
0.83
0.39
1.4
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
19
0.00
0.39
0.0
2.0
—
10.7
—
0
14
(4281824)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
38
327
1.18
0.39
1.4
2.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
42
365
1.17
0.38
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
111
0.71
0.38
2.4
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
256
0.81
0.37
3.0
3.2
%
32.1
31.2
0.14
16
189
(3032773) Endomysium IgG Ab [Titer] in Serum
5
37
1.36
0.37
1.6
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
112
1044
1.11
0.36
3.6
5.8
mmol/l
1.2
1.2
0.05
95
882
(3037522) Nuclear Ab [Titer] in Serum
53
472
1.14
0.36
1.5
1.4
titre
629.1
439.3
0.51
11
107
(46235355) HIV 1 and 2 tests - Meaningful Use set
134
1261
1.10
0.36
2.2
2.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
330
1.17
0.36
1.2
1.3
iu/ml
90.1
145.3
0.50
18
137
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
23
190
1.22
0.35
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
71
777
0.89
0.35
2.0
2.8
mmol/l
2.4
2.3
0.37
64
703
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
68
618
1.12
0.34
2.2
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
683
0.89
0.34
4.4
5.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
86
0.69
0.33
2.8
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
46
1.31
0.33
1.5
1.5
—
—
—
0
0
(4010399)
19
155
1.24
0.33
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
154
0.77
0.32
2.2
2.3
ug/l
0.5
0.7
—
6
73
(3017143) Hepatitis C virus Ab [Presence] in Serum
64
582
1.12
0.32
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
296
1.16
0.32
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
43
482
0.88
0.31
4.2
4.5
mg/mmol
1.0
12.4
4.36
29
326
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
662
1.11
0.30
1.5
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
91
848
1.10
0.30
1.7
1.7
pmol/l
95.9
98.7
0.29
59
459
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
167
1.21
0.29
1.2
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
109
1026
1.09
0.29
1.7
1.7
—
—
—
0
0
(3020891) Body temperature
8
62
1.30
0.28
1.5
4.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
196
1.19
0.27
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
95
1.27
0.26
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
95
1.27
0.26
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
493
1.11
0.26
1.5
1.7
%
1.2
1.4
0.81
47
450
(3044290) Cell count panel - Cerebral spinal fluid
8
67
1.20
0.26
1.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
181
0.82
0.26
1.7
2.1
ml/min/173m2
89.2
79.5
—
6
71
(3048689) Calprotectin [Mass/mass] in Stool
47
516
0.90
0.25
2.9
2.2
ug/g
99.6
105.2
0.07
39
402
(3013826) Glucose [Moles/volume] in Serum or Plasma
154
1478
1.07
0.25
2.9
4.2
mmol/l
6.2
6.3
0.12
139
1311
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
75
1.21
0.25
3.6
16.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
96
1.26
0.25
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
96
1.26
0.25
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
130
1241
1.07
0.24
2.5
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
83
0.72
0.24
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
61
564
1.10
0.24
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
98
926
1.08
0.24
2.3
3.1
e6/l
54.1
57.8
0.05
65
576
(42870588) Differential panel, method unspecified - Blood
85
902
0.92
0.23
6.8
5.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
97
918
1.08
0.23
2.7
5.4
mmol/l
1.2
1.2
0.07
86
845
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
242
0.86
0.23
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
32
357
0.89
0.23
1.8
2.4
ng/l
230.2
464.2
1.70
27
278
(3028707) Methadone [Presence] in Urine by Screen method
11
135
0.81
0.22
1.7
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
60
645
0.92
0.22
2.9
3.3
mmol/l
8.1
8.4
0.16
55
569
(3032080) INR in Blood by Coagulation assay
80
753
1.08
0.22
7.1
5.1
inr
1.1
1.0
0.54
30
269
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
188
0.84
0.22
1.3
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
98
1.23
0.21
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
11
0.00
0.21
0.0
3.1
—
2027.3
—
0
11
(3012441) Differential panel - Pleural fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
10
0.00
0.21
0.0
31.6
—
7.0
—
0
10
(40768806) Pleura Pathology biopsy report
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.7
—
1794.4
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
66.1
—
0
7
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
24.6
—
0
12
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.1
—
0
7
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
27.2
—
0
13
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.7
—
6.7
—
0
13
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
14
117
1.20
0.21
1.2
2.0
ug/l
3.4
6.5
0.87
14
108
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
165
0.84
0.20
1.4
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
146
1.17
0.19
1.4
1.3
—
1.3
—
0
8
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
52
1.16
0.19
1.5
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
52
1.16
0.19
1.2
3.3
—
1110.0
—
0
5
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
52
1.16
0.19
3.0
3.8
e9/l
3.0
4.4
—
6
52
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
52
1.16
0.19
3.0
3.9
%
52.5
57.3
—
6
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
100
1.21
0.18
2.3
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
274
2697
1.07
0.18
2.9
3.2
mmol/l
5.5
5.6
0.91
261
2523
(4306422)
7
60
1.17
0.18
1.3
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
157
1.15
0.17
1.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
61
1.15
0.17
2.3
2.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
466
1.08
0.17
2.1
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
131
0.83
0.17
1.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
129
1.17
0.17
1.1
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
67
0.74
0.17
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
275
2709
1.06
0.17
6.4
8.2
ml/min/173m2
93.8
96.5
1.55
228
2157
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
69
0.72
0.17
1.2
1.0
u/ml
1.3
2.1
—
5
35
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
656
0.93
0.16
1.8
1.6
mmol/l
1.3
1.4
0.33
52
586
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
204
1996
1.05
0.16
6.1
6.5
u/l
67.4
72.0
1.40
193
1886
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
73
1.10
0.16
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
6
77
0.78
0.15
1.0
1.2
u/ml
251.0
220.8
—
6
47
(3012516) Albumin [Mass/volume] in Urine
43
460
0.93
0.15
3.3
3.7
mg/l
3143.4
372.0
0.67
27
309
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
87
0.80
0.14
1.0
1.3
—
2.6
—
0
12
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
88
0.79
0.14
1.0
1.3
—
14.8
—
0
19
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
122
1.15
0.14
1.6
2.0
u/l
40.3
39.4
0.07
14
113
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
98
0.81
0.14
1.0
1.3
—
25.0
—
0
8
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
99
0.80
0.14
1.0
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
273
0.91
0.13
1.4
2.2
%
23.4
25.8
0.28
16
238
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
159
0.88
0.13
1.3
6.0
mmol/l
1.2
1.3
0.37
14
154
(3019225) pH of Specimen
17
190
0.89
0.13
2.1
3.7
—
—
—
0
0
(3013512) EKG study
58
551
1.06
0.13
2.4
2.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
148
0.87
0.12
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
69
660
1.06
0.12
1.9
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
210
0.90
0.12
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
146
1428
1.04
0.10
5.7
5.5
%
31.2
30.1
0.78
141
1361
(3043409) Potassium [Moles/volume] in Arterial blood
5
44
1.14
0.10
1.4
4.5
mmol/l
3.7
3.7
—
5
39
(3019832) Treponema pallidum Ab [Presence] in Serum
91
883
1.04
0.10
2.0
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
75
725
1.04
0.09
1.9
2.6
e6/l
22.9
50.8
1.26
61
533
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
4.6
6.8
umol/l
354.6
392.8
—
5
42
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
866
0.96
0.09
1.7
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
278
0.93
0.09
1.5
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
14
126
1.12
0.09
1.1
2.0
g/l
68.9
67.7
0.49
14
117
(3045424) Erythrocytes [Presence] in Urine
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
206
0.92
0.09
2.4
3.3
%
18.6
21.4
—
6
68
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
61
0.82
0.08
1.6
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
63
0.79
0.08
1.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
195
1.08
0.08
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
14
127
1.11
0.08
1.1
1.2
ug/l
3.4
3.3
0.03
14
117
(3023368) Bacteria identified in Blood by Culture
50
481
1.05
0.07
3.0
4.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
75
1.07
0.07
1.1
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
76
1.05
0.07
1.0
1.3
—
33.9
—
0
9
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
77
1.04
0.07
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
82
0.85
0.07
1.1
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
66
641
1.04
0.07
1.9
2.5
e6/l
0.1
0.3
1.91
53
464
(3027944) Amphetamines [Presence] in Urine
28
295
0.94
0.06
1.4
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
133
1310
1.02
0.06
5.9
5.6
%
0.7
0.7
0.46
128
1237
(3000991) Gas panel - Venous blood
12
130
0.92
0.04
1.3
7.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
298
1.04
0.04
1.6
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
61
623
0.97
0.04
2.2
3.4
ph
7.4
7.4
1.14
11
110
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
360
1.03
0.03
1.5
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
122
1.07
0.02
1.7
2.2
umol/l
3.4
4.9
—
7
90
(3028300) Cannabinoids [Presence] in Urine
29
298
0.97
0.02
1.4
1.9
—
—
—
0
0
(3000492) Spirometry study
30
308
0.97
0.02
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
135
1359
0.99
0.01
6.0
5.5
%
2.7
2.7
0.16
130
1281
(3022621) pH of Urine by Test strip
18
173
1.04
0.01
2.4
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
423
1.02
0.01
1.7
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
116
0.95
0.00
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
296
0.98
0.00
1.4
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
278
2786
0.99
0.00
4.0
4.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
137
1364
1.01
0.00
6.0
5.8
%
8.5
7.9
1.95
131
1299
(3011288) Drugs identified in Urine by Screen method
21
212
0.99
0.00
1.6
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
99
1.01
0.00
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
101
0.99
0.00
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
239
1.00
0.00
1.5
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
309
1.00
0.00
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
123
0.97
0.00
1.9
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
31
307
1.01
0.00
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
125
1.04
0.00
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
29
295
0.98
0.00
1.4
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
355
1.02
0.00
3.0
2.3
u/l
3681.1
4277.3
0.07
17
160
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
134
0.97
0.00
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
56
0.89
0.00
1.2
1.6
—
12.5
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.4
—
0
5
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.1
—
1.2
—
0
9
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
83
0.96
0.00
1.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
80
1.00
0.00
1.5
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.0
—
1.2
—
0
7
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
66
0.91
0.00
1.5
2.3
mg/l
7.5
9.7
—
6
60
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
61
0.98
0.00
1.0
1.0
—
0.6
—
0
14
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
9.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
68
0.88
0.00
1.3
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
630
1.00
0.00
3.5
3.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
63
0.95
0.00
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
94
0.96
0.00
1.2
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
80
1.00
0.00
1.0
1.2
—
117.0
—
0
16
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
13.0
—
0
8
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036489) Thrombin time
12
120
1.00
0.00
1.3
1.6
s
20.8
20.3
—
6
102
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
86
0.93
0.00
1.0
1.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OPEN_BITE_SURGERY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_OPEN_BITE_SURGERY.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_OPEN_BITE_SURGERY – Open bite that required surgery (Lefort1 or BSSRO)

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data